This study is in progress, not accepting new patients
VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03400176
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- About 39 people participating
- Last Updated